logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

John Nemunaitis

gradalis inc

92H指数
808论文数
3.6W被引数
收录论文 177
发表时间
logo
In Vivo Assessment of dbDNA GNEwt/bi-shRNA-GNEM743T Lipoplex for GNE Myopathy: Improved Potency and Safety体内评估dbDNA GNEwt/bi-shRNA-GNEM743T脂质体复合物对GNE肌病的疗效与安全性：功效与安全性的提升
errThe Journal of Gene Medicine
IF0
err2026-05-26
err0
errOAAI
errChristopher M. Jay; Fabienne Kerneis; Donald Rao; Alexander Nemunaitis; Ernest Bognar; Gladice Wallraven; Laura Stanbery; Rebecca Lutz; Adam Walter; Sep Sarshar; John Nemunaitis
err分享
err收藏
Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product外显子组测序显示自体肿瘤和Vigil产物之间的克隆肿瘤突变负荷，肿瘤内异质性和克隆新抗原的相同模式
errSCIENTIFIC REPORTS
IF3.9
err2025-03-13
err1
errOAAI
errWilloughby, David; Bognar, Ernest; Stanbery, Laura; Nagel, Casey; Wallraven, Gladice; Pruthi, Aman; Bild, Nicholas; Stamper, Ericca; Rao, Donald; Walter, Adam; Nemunaitis, John
err分享
err收藏
Clinical characterization and therapeutic targeting of fusion genes in oncology
errFUTURE ONCOLOGY
IF2.6
err2025-03-01
err0
errOAAI
errMorand, Susan; Rager, Lauren; Craig, Daniel; Nemunaitis, Alexander; Choucair, Khalil; Rao, Donald; Stanbery, Laura; Phinney, Richard C.; Walter, Adam; Ghisoli, Maurizio; Nemunaitis, John
err分享
err收藏
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapyGemogenovatucel-t (Vigil): 基于bi-shrna质粒的靶向免疫治疗
errFUTURE ONCOLOGY
IF2.6
err2024-08-05
err2
errOAAI
errNemunaitis, John; Stanbery, Laura; Walter, Adam; Wallraven, Gladice; Nemunaitis, Alexander; Horvath, Staci; Bognar, Ernest; Rao, Donald; Engle, Steven; Brun, Scott; Ghisoli, Maurizio; Rocconi, Rodney P.; Monk, Bradley J.; Coleman, Robert L.
err分享
err收藏
3D engineered scaffold for large-scale Vigil immunotherapy production
errSCIENTIFIC REPORTS
IF3.9
err2024-07-05
err0
errOAAI
errKerneis, Fabienne; Bognar, Ernest; Stanbery, Laura; Moon, Seongjun; Kim, Do Hoon; Deng, Yuxuan; Hughes, Elliot; Chun, Tae-Hwa; Tharp, Darron; Zupanc, Heidi; Jay, Chris; Walter, Adam; Nemunaitis, John; Lahann, Joerg
err分享
err收藏
Regulatory role of CD39 and CD73 in tumor immunityCD39和CD73在肿瘤免疫中的调节作用
errFUTURE ONCOLOGY
IF2.6
err2024-04-23
err7
errOAAI
errKaplinsky, Nicole; Williams, Kada; Watkins, Dean; Adams, Molly; Stanbery, Laura; Nemunaitis, John
err分享
err收藏
Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer使用同源重组熟练分子谱作为卵巢癌治疗靶向生物标志物的原理
errONCOLOGY REVIEWS
IF5.2
err2023-09-20
err4
errOAAI
errNemunaitis, John; Stanbery, Laura; Walter, Adam; Rocconi, Rodney; Stephens, Philip
err分享
err收藏
Advances in Targeted Therapy for the Treatment of Cervical Cancer宫颈癌靶向治疗的研究进展
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2023-09-15
err14
errOAAI
errWatkins, Dean E.; Craig, Daniel J.; Vellani, Shahnaz D.; Hegazi, Ahmad; Fredrickson, Kaylee J.; Walter, Adam; Stanbery, Laura; Nemunaitis, John
err分享
err收藏
A Scalable Engineered Extracellular Matrix Platform to Expand Tumor Cells可扩展的工程化细胞外基质平台以扩增肿瘤细胞
errADVANCED NANOBIOMED RESEARCH
IF4.4
err2023-06-04
err3
errOAAI
errMoon, Seongjun; Neale, Dylan B.; Kim, Do Hoon; Mukherji, Malini; Hughes, Elliot; Deng, Yuxuan; Kerneis, Fabienne; Luo, Xiuquan; Tharp, Darron; Bognar, Ernest; Stanbery, Laura; Nemunaitis, John; Chun, Tae-Hwa; Lahann, Joerg
err分享
err收藏
ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer (vol 2, 106, 2022)
errCOMMUNICATIONS MEDICINE
IF6.3
err2023-05-05
err0
errOAAI
errRocconi, Rodney P.; Stanbery, Laura; Tang, Min; da Silva, Luciana Madeira; Walter, Adam; Monk, Bradley J.; Herzog, Thomas J.; Coleman, Robert L.; Manning, Luisa; Wallraven, Gladice; Horvath, Staci; Bognar, Ernest; Senzer, Neil; Brun, Scott; Nemunaitis, John
err分享
err收藏
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNAVigil/替莫唑胺/伊立替康治疗复发性尤因肉瘤的初步研究和循环肿瘤 (ct) DNA的评估
errCLINICAL CANCER RESEARCH
IF10.2
err2023-02-13
err8
errOAAI
errAnderson, Peter; Ghisoli, Maurizio; Crompton, Brian D.; Klega, Kelly S.; Wexler, Leonard H.; Slotkin, Emily K.; Stanbery, Laura; Manning, Luisa; Wallraven, Gladice; Manley, Meghan; Horvath, Staci; Bognar, Ernest; Nemunaitis, John
err分享
err收藏
Systemic benefit of radiation therapy via abscopal effect通过远视效应进行放射治疗的全身益处
errFRONTIERS IN ONCOLOGY
IF3.3
err2022-10-25
err7
errOAAI
errCraig, Daniel J. J.; Ambrose, Stephanie; Stanbery, Laura; Walter, Adam; Nemunaitis, John
err分享
err收藏
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer聚焦于乳腺癌和卵巢癌的肿瘤通路中的nf-κb信号传导
errONCOLOGY REVIEWS
IF5.2
err2022-10-03
err28
errOAAI
errDevanaboyina, Monika; Kaur, Jasskiran; Whiteley, Emma; Lin, Leslie; Einloth, Katelyn; Morand, Susan; Stanbery, Laura; Hamouda, Danae; Nemunaitis, John
err分享
err收藏
ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancerENTPD1/CD39作为新诊断卵巢癌维持治疗对吉非替尼治疗反应的预测指标
errCOMMUNICATIONS MEDICINE
IF6.3
err2022-08-29
err11
errOAAI
errRocconi, Rodney P.; Stanbery, Laura; Tang, Min; da Silva, Luciana Madeira; Walter, Adam; Monk, Bradley J.; Herzog, Thomas J.; Coleman, Robert L.; Manning, Luisa; Wallraven, Gladice; Horvath, Staci; Bognar, Ernest; Senzer, Neil; Brun, Scott; Nemunaitis, John
err分享
err收藏
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study探索伊塔替尼联合epacadostat或parsaclisib治疗晚期实体瘤的安全性，对肿瘤微环境的影响和疗效: 一期研究
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2022-03-14
err12
errOAAI
errNaing, Aung; Powderly, John D.; Nemunaitis, John J.; Luke, Jason J.; Mansfield, Aaron S.; Messersmith, Wells A.; Sahebjam, Solmaz; LoRusso, Patricia M.; Garrido-Laguna, Ignacio; Leopold, Lance; Geschwindt, Ryan; Ding, Kai; Smith, Michael; Berlin, Jordan D.
err分享
err收藏
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept StudyPembrolizumab联合Acalabrutinib治疗晚期头颈部鳞状细胞癌的安全性和有效性: 2期概念验证研究
errCLINICAL CANCER RESEARCH
IF10.2
err2021-12-02
err18
errOAAI
errTaylor, Matthew H.; Betts, Courtney B.; Maloney, Lauren; Nadler, Eric; Algazi, Alain; Guarino, Michael J.; Nemunaitis, John; Jimeno, Antonio; Patel, Priti; Munugalavadla, Veerendra; Tao, Lin; Adkins, Douglas; Goldschmidt, Jerome H., Jr.; Cohen, Ezra E. W.; Coussens, Lisa M.
err分享
err收藏
Network based analysis identifies TP53m-BRCA1/2wt-homologous recombination proficient (HRP) population with enhanced susceptibility to Vigil immunotherapy基于网络的分析确定TP53m-BRCA1/2wt同源重组熟练 (HRP) 人群对Vigil免疫疗法的易感性增强
errCANCER GENE THERAPY
IF5
err2021-11-16
err6
errOAAI
errSliheet, Elyssa; Robinson, Molly; Morand, Susan; Choucair, Khalil; Willoughby, David; Stanbery, Laura; Aaron, Phylicia; Bognar, Ernest; Nemunaitis, John
err分享
err收藏
Homologous recombination proficiency in ovarian and breast cancer patients卵巢癌和乳腺癌患者的同源重组能力
errBMC CANCER
IF3.4
err2021-10-28
err62
errOAAI
errCreeden, Justin Fortune; Nanavaty, Nisha S.; Einloth, Katelyn R.; Gillman, Cassidy E.; Stanbery, Laura; Hamouda, Danae M.; Dworkin, Lance; Nemunaitis, John
err分享
err收藏
Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6病例报告: 两名接受Vigil和FOLFOX-6治疗的结直肠癌肝转移患者的显着生存优势
errVACCINES
IF3.4
err2021-10-18
err4
errOAAI
errBarve, Vedin; Adams, Ned; Stanbery, Laura; Manning, Luisa; Horvath, Staci; Wallraven, Gladice; Bognar, Ernest; Barve, Minal; Nemunaitis, John
err分享
err收藏
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancerp70S6K/AKT双重抑制剂M2698在晚期癌症患者中的1期研究
errJOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
err2021-08-18
err13
errOAAI
errTsimberidou, Apostolia-Maria; Shaw, Jamie V.; Juric, Dejan; Verschraegen, Claire; Weise, Amy M.; Sarantopoulos, John; Lopes, Gilberto; Nemunaitis, John; Mita, Monica; Park, Haeseong; Ellers-Lenz, Barbara; Tian, Hui; Xiong, Wenyuan; Kaleta, Remigiusz; Kurzrock, Razelle
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
R
Richard A. Gibbs
H 指数: 190 · 论文数: 1.3K
M
Michael J. Mack
H 指数: 167 · 论文数: 1.4K
A
Adi F. Gazdar
H 指数: 161 · 论文数: 1.2K
J
Jean‐Yves Blay
H 指数: 158 · 论文数: 2.4K
A
Antoni Ribas
H 指数: 158 · 论文数: 1.7K
查看更多